// App-Quantinova.ai

145 : Development of New International Classification Criteria for Antiphospholipid Syndrome: Phase II Results

Researchers

Presenter

  • Stephane Zuily

Principal Investigators

  • Yasaman Ahmadzadeh

  • Raymond Naden

  • Karen Costenbader

  • Doruk Erkan

Medical Centers

  • Hospital for Special Surgery, Weill Cornell Medical College, New York, NY

  • Centre Hospitalier Universitaire, Ottignies, France

  • N/A, Tehran, Iran

  • McMaster University, Hamilton, ON, Canada

  • Brigham and Women's Hospital, Brookline, MA

  • Hospital for Special Surgery, New York, NY.

  • Hospital for Special Surgery, New York, NY.

Locations

  • United States

  • France

  • Iran

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved